The May formulary updates include the addition of 99 new National Drug Codes (NDCs), representing 52 different prescription drugs, many with multiple strengths.
The formulary updates impact both stand-alone Medicare Part D plans (PDPs) and Medicare Advantage plans with drug coverage (MAPDs).
Highlights of the May 2024 Formulary updates include ten (10) newly-introduced brand-name drugs
The May drug data updates include fifteen (15) new brand-name drugs, ten (10) of which are newly introduced brand-name drugs, some with multiple strengths. These drugs include:
- CABTREO®,
- IXCHIQ®,
- JOENJA®,
- MOTPOLY XR®,
- NEXICLON XR®,
- OZOBAX DS®,
- ProctoFoam HC®,
- QDOLO®,
- RIVFLOZA®, and
- VEVYE®.
The May 2024 Formulary updates include ten (10) newly-added generic drugs
The May Medicare Part D drug data also includes thirty-seven (37) new generic medications, ten (10) of which are newly-introduced generic drugs. These new generic drugs include:
- AMETHIA [Simpesse®],
- BISOPROLOL FUMARATE [Zebeta®],
- BROMFENAC SOD [BromSite®],
- CETIRIZINE HCL [Zyrtec Syrup®],
- CYCLOSERINE [Seromycin®],
- DEFLAZACORT [Emflaza®],
- HEATHER [Sharobel 28-Day®],
- LOTEPREDNOL ETABONATE [Alrex®],
- MIFEPRISTONE [Korlym®], and
- TRIENTINE HCL®].
You can read more about the new generics in our article: May 2024 Drug List Updates: Thirty-seven (37) new generic drugs added to many Medicare Part D plan formularies.
Reminders about Medicare prescription drug plan formulary changes
- Medicare Part D plans (PDPs and MAPDs) can change their formulary or drug list during the year and may drop one of your formulary medication mid-year for specific Medicare-allowable reasons (such as a new generic drug is available), but there are steps you can take if your medication is no longer covered by your prescription drug plan.
- In most cases, your Medicare Part D plan
will notify you if the plan drops a medication you are currently using.
The NDC or National Drug Code is used to uniquely identify a particular drug, manufacturer, strength, and packaging combination. The NDC is often shown on your prescription bottle as an 11-digit code (see the charts below) or could be formatted as 00000-0000-00 where the first set of numbers identifies the drug manufacturer, the second set of number identifies the product and strength, and the third set of numbers identifies the packaging. You can read more on this site
Summary of May 2024 NDC changes
There are many reasons for NDCs to be added to the Medicare Part D program, a summary for all 99 new May 2024 NDCs is as follows:
| Reason for NDC Addition | Occurrences |
| New Delivery Form | 2 |
| New Delivery Form and Strength | 2 |
| New Drug | 30 |
| New Drug and Strength | 22 |
| New Drug, Delivery Form and Strength | 1 |
| New Drug, Manufacturer and Strength | 4 |
| New Manufacturer | 2 |
| New Manufacturer and Delivery Form | 1 |
| New Manufacturer and Strength | 21 |
| New Manufacturer, Delivery Form and Strength | 6 |
| New Strength | 8 |
| Grand Total | 99 |
The following chart details the 99 new manufacturer / drug-strength / packaging combinations (NDCs) that were added to one or more Medicare Part D formularies in the most recent updates -- as you will notices, some drugs are only covered by a few Medicare plans.
You can click on the Drug Name below to go to our on this site Drug Finder ( on this site) and see the details of how this drug is covered by all Medicare Part D plans (PDPs) in Florida (our example state). You can then change the state in our search form for details of drug coverage in your service area.
| NDC | Drug Name | Number of PDP Formularies* |
Number of MAPD Formularies* |
Notes |
| 65219061299 | ADALIMUMAB-AACF(CF) PEN 40 MG PEN IJ KIT [Idacio] | 2 | 27 | New Drug |
| 00480927706 | ALYQ 20 MG TABLET [Cialis] | 28 | 252 | New Drug |
| 51862004701 | AMETHIA 0.15-0.03-0.01 MG TABLET TBDSPK 3MO [Simpesse] | 27 | 217 | New Drug |
| 66794020815 | AMPICILLIN-SULBACTAM 15 GM VIAL [Unasyn] | 38 | 339 | New Manufacturer and Strength |
| 68382000301 | AZATHIOPRINE 50 MG TABLET [Imuran] | 54 | 369 | New Drug |
| 00168026850 | BETAMETHASONE DP AUG 0.05% OINTMENT [Diprolene] | 54 | 364 | New Manufacturer and Delivery Form |
| 70954045620 | BISOPROLOL FUMARATE 10 MG TABLET [Zebeta] | 54 | 368 | New Drug and Strength |
| 70954045520 | BISOPROLOL FUMARATE 5 MG TABLET [Zebeta] | 54 | 368 | New Drug and Strength |
| 42799092001 | BISOPROLOL-HCTZ 2.5-6.25 MG TABLET [Ziac] | 52 | 368 | New Strength |
| 42799092101 | BISOPROLOL-HCTZ 5-6.25 MG TABLET [Ziac] | 52 | 368 | New Strength |
| 70069023101 | BRIMONIDINE 0.2% EYE DROPS [Alphagan] | 54 | 369 | New Drug |
| 49708075541 | BROMFENAC SOD 0.075% EYE DROPS [BromSite] | 2 | 85 | New Drug |
| 69238120302 | BUPRENORPHINE 10 MCG/HR PATCH [Butrans] | 15 | 216 | New Drug and Strength |
| 69238120402 | BUPRENORPHINE 15 MCG/HR PATCH [Butrans] | 15 | 216 | New Drug and Strength |
| 69238120502 | BUPRENORPHINE 20 MCG/HR PATCH [Butrans] | 15 | 216 | New Drug and Strength |
| 00054017613 | BUPRENORPHINE 2 MG TABLET SUBLIGUAL [Subutex] | 54 | 369 | New Drug, Manufacturer and Strength |
| 00187000625 | CABTREO 1.2%-0.15%-3.15% GEL | 0 | 1 | New Drug |
| 65862070020 | CEFUROXIME AXETIL 500 MG TABLET [Ceftin] | 54 | 369 | New Manufacturer and Strength |
| 00121087416 | CETIRIZINE HCL 1 MG/ML SOLUTION [Zyrtec Syrup] | 28 | 216 | New Drug |
| 68462029735 | CICLOPIROX 0.77% CREAM (G) [Loprox] | 53 | 368 | New Manufacturer, Delivery Form and Strength |
| 61314065605 | CIPROFLOXACIN 0.3% EYE DROPS [Ciloxan] | 54 | 369 | New Drug |
| 00009766705 | CLEOCIN 100 MG VAGINAL OVULE SUPP.VAG | 2 | 54 | New Drug |
| 52817037530 | CLONIDINE HCL ER 0.17 MG TABLET 24H | 0 | 4 | New Manufacturer and Strength |
| 13107032001 | CLORAZEPATE 7.5 MG TABLET [Tranxene T-Tab] | 54 | 368 | New Drug |
| 00574010770 | CLOTRIMAZOLE 10 MG TROCHE [Mycelex Troche] | 54 | 369 | New Drug |
| 70010000201 | COLCHICINE 0.6 MG TABLET [Colcrys] | 53 | 367 | New Drug |
| 43598023531 | CYCLOSERINE 250 MG CAPSULE [Seromycin] | 17 | 91 | New Drug |
| 60505434906 | DABIGATRAN ETEXILATE 110 MG CAPSULE [Pradaxa] | 32 | 170 | New Drug, Manufacturer and Strength |
| 31722062260 | DABIGATRAN ETEXILATE 150 MG CAPSULE [Pradaxa] | 44 | 269 | New Drug, Manufacturer and Strength |
| 31722062160 | DABIGATRAN ETEXILATE 75 MG CAPSULE [Pradaxa] | 44 | 269 | New Drug, Manufacturer and Strength |
| 67877044460 | DALFAMPRIDINE ER 10 MG TABLET 12H [Ampyra] | 54 | 369 | New Drug |
| 83649033001 | DARAPRIM 25 MG TABLET | 0 | 5 | New Drug |
| 59651060030 | DEFLAZACORT 18 MG TABLET [Emflaza] | 0 | 15 | New Drug and Strength |
| 59651060130 | DEFLAZACORT 30 MG TABLET [Emflaza] | 0 | 15 | New Drug and Strength |
| 59651060230 | DEFLAZACORT 36 MG TABLET [Emflaza] | 0 | 15 | New Drug and Strength |
| 59651059901 | DEFLAZACORT 6 MG TABLET [Emflaza] | 0 | 15 | New Drug and Strength |
| 70436001304 | DESVENLAFAXINE SUCCNT ER 100MG TABLET 24H [Pristiq] | 54 | 369 | New Manufacturer and Strength |
| 00781235201 | DEXTROAMP-AMPHET ER 20 MG CAPSULE 24H [Adderall XR] | 50 | 334 | New Manufacturer and Strength |
| 00781237101 | DEXTROAMP-AMPHET ER 30 MG CAPSULE 24H [Adderall XR] | 50 | 334 | New Manufacturer and Strength |
| 72205004060 | DOFETILIDE 250 MCG CAPSULE [Tikosyn] | 54 | 369 | New Manufacturer and Strength |
| 72205004160 | DOFETILIDE 500 MCG CAPSULE [Tikosyn] | 54 | 369 | New Manufacturer and Strength |
| 45802046653 | ECONAZOLE NITRATE 1% CREAM (G) [Spectazole] | 30 | 281 | New Drug |
| 00781324664 | ENOXAPARIN 40 MG/0.4 ML SYRINGE [Lovenox] | 54 | 369 | New Manufacturer and Strength |
| 60505619604 | ERTAPENEM 1 GRAM VIAL [Invanz] | 54 | 369 | New Drug |
| 66993000210 | ESTRADIOL 0.01% CREAM/APPL [Estrace] | 54 | 368 | New Manufacturer, Delivery Form and Strength |
| 00781714483 | ESTRADIOL 0.05 MG PATCH (2/WK) PATCH TDSW [Vivelle-Dot] | 48 | 350 | New Manufacturer and Strength |
| 69315028209 | FENOFIBRIC ACID DR 135 MG CAPSULE [Trilipix] | 27 | 289 | New Manufacturer and Strength |
| 45963055650 | GABAPENTIN 300 MG CAPSULE [Neurontin] | 54 | 369 | New Manufacturer and Strength |
| 67457040913 | HALOPERIDOL DEC 100 MG/ML VIAL [Haldol Decanoate] | 54 | 366 | New Strength |
| 68462030329 | HEATHER 0.35 MG TABLET [Sharobel 28-Day] | 41 | 221 | New Drug |
| 83457010301 | CDV HYRIMOZ 40 MG/0.8 ML SYRINGE | 0 | 5 | New Manufacturer and Strength |
| 83457010201 | CDV HYRIMOZ PEN 40 MG/0.8 ML PEN INJECTOR | 0 | 5 | New Manufacturer and Strength |
| 70954063710 | INDOMETHACIN 25 MG/5 ML ORAL SUSPENSION [Indocin] | 0 | 3 | New Manufacturer, Delivery Form and Strength |
| 24208039830 | IPRATROPIUM 0.03% SPRAY [Atrovent] | 54 | 369 | New Manufacturer, Delivery Form and Strength |
| 24208039915 | IPRATROPIUM 0.06% SPRAY [Atrovent] | 54 | 369 | New Manufacturer, Delivery Form and Strength |
| 42515000301 | IXCHIQ Chikungunya 18 Years + Injectable 0.5mL Live SDV Ea | 41 | 228 | New Drug |
| 71274017060 | JOENJA 70 MG TABLET | 2 | 45 | New Drug |
| 62332017460 | LACOSAMIDE 200 MG TABLET [Vimpat] | 54 | 369 | New Manufacturer and Strength |
| 72485065305 | LOTEPREDNOL ETABONATE 0.2% DRP EYE DROPPER [Alrex] | 9 | 88 | New Drug and Strength |
| 72485066505 | LOTEPREDNOL ETABONATE 0.5% DRP EYE DROPPER [Lotemax] | 14 | 181 | New Drug and Strength |
| 71717010611 | METFORMIN HCL 1,000 MG TABLET [Glucophage] | 54 | 369 | New Manufacturer and Strength |
| 13811070810 | METHYLPHENIDATE ER 36 MG TABLET 24H [RELEXXII] | 8 | 161 | New Strength |
| 13811070910 | METHYLPHENIDATE ER 54 MG TABLET 24H [RELEXXII] | 8 | 161 | New Strength |
| 00591439096 | MIFEPRISTONE 300 MG TABLET [Korlym] | 41 | 239 | New Drug |
| 73289006302 | MOTPOLY XR 100 MG CAPSULE ER 24H | 0 | 36 | New Drug and Strength |
| 73289006402 | MOTPOLY XR 150 MG CAPSULE ER 24H | 5 | 44 | New Drug and Strength |
| 73289006502 | MOTPOLY XR 200 MG CAPSULE ER 24H | 5 | 44 | New Drug and Strength |
| 71511070116 | NAPROSYN 125 MG/5 ML ORAL SUSPENSION | 0 | 1 | New Drug |
| 69784050001 | EC-NAPROXEN DR 500 MG TABLET [EC-Naprosyn] | 50 | 328 | New Manufacturer and Strength |
| 43547052603 | NEBIVOLOL 10 MG TABLET [Bystolic] | 40 | 352 | New Drug and Strength |
| 43547052403 | NEBIVOLOL 2.5 MG TABLET [Bystolic] | 40 | 352 | New Drug and Strength |
| 43547052703 | NEBIVOLOL 20 MG TABLET [Bystolic] | 40 | 352 | New Drug and Strength |
| 43547052503 | NEBIVOLOL 5 MG TABLET [Bystolic] | 40 | 352 | New Drug and Strength |
| 71511050330 | NEXICLON XR 0.17 MG TABLET ER 24H | 0 | 2 | New Drug |
| 69528030216 | OZOBAX DS 10 MG/5 ML SOLUTION | 0 | 5 | New Drug |
| 43975035003 | PALIPERIDONE ER 3 MG TABLET 24H [Invega] | 54 | 369 | New Strength |
| 43975035103 | PALIPERIDONE ER 6 MG TABLET 24H [Invega] | 54 | 369 | New Strength |
| 70010014701 | POTASSIUM CL ER 8 MEQ CAPSULE ER [Micro-K Extencaps] | 52 | 366 | New Manufacturer and Strength |
| 69097068105 | PREGABALIN 100 MG CAPSULE [Lyrica] | 54 | 369 | New Manufacturer and Strength |
| 00037682210 | PROCTOFOAM-HC 1%-1% FOAM | 0 | 24 | New Drug |
| 71511030116 | QDOLO 5 MG/ML SOLUTION | 0 | 6 | New Drug |
| 65862087011 | RISEDRONATE SODIUM 150 MG TABLET [Actonel] | 17 | 322 | New Manufacturer and Strength |
| 00169530708 | RIVFLOZA 128 MG/0.8 ML SYRINGE | 2 | 37 | New Drug and Strength |
| 00169530610 | RIVFLOZA 160 MG/ML SYRINGE | 2 | 35 | New Drug and Strength |
| 00169530801 | RIVFLOZA 80 MG/0.5 ML VIAL | 2 | 37 | New Drug, Delivery Form and Strength |
| 50242062342 | ROZLYTREK 50 MG PELLET PACKET | 41 | 246 | New Delivery Form and Strength |
| 27241012403 | SILDENAFIL 20 MG TABLET [Revatio] | 54 | 369 | New Manufacturer, Delivery Form and Strength |
| 70512084111 | SODIUM CHLORIDE 0.9% IV SOLUTION | 54 | 369 | New Manufacturer |
| 00143965901 | TESTOSTERONE CYP 200 MG/ML VIAL [Virilon] | 54 | 365 | New Manufacturer |
| 27241019130 | TOLTERODINE TART ER 2 MG CAPSULE 24H [Detrol LA] | 51 | 363 | New Drug and Strength |
| 27241019230 | TOLTERODINE TART ER 4 MG CAPSULE 24H [Detrol LA] | 51 | 363 | New Drug and Strength |
| 16571081205 | TRIENTINE HCL 500 MG CAPSULE | 11 | 87 | New Drug |
| 70010002703 | TROSPIUM CHLORIDE ER 60 MG CAPSULE 24H [Sanctura XR] | 8 | 213 | New Drug |
| 82667090002 | VEVYE 0.1% EYE DROPS | 0 | 4 | New Drug |
| 62332023430 | VILAZODONE HCL 40 MG TABLET [VIIBRYD] | 54 | 366 | New Manufacturer and Strength |
| 50242021555 | XOLAIR 150 MG/ML AUTOINJECTOR | 41 | 243 | New Delivery Form |
| 50242022755 | XOLAIR 300 MG/2 ML AUTOINJECTOR | 41 | 243 | New Delivery Form and Strength |
| 50242022701 | XOLAIR 300 MG/2 ML SYRINGE | 41 | 244 | New Strength |
| 50242021455 | XOLAIR 75 MG/0.5 ML AUTOINJECTOR | 41 | 243 | New Delivery Form |
- Ask your prescriber about trying the generic.
- Check for an alternative formulary drug.
- Ask your plan to cover a non-formulary drug.
You will need to work with your doctor or prescriber to explain why you are not able to use the generic medication or why no other formulary drug is acceptable. If your formulary exception is denied, you have the right to appeal your plan’s decision.
- Consider using a Special Enrollment Period and move to another Medicare plan that provides coverage of all your prescription and health needs.
Our online Formulary Browser and Drug Finder
You can review any Medicare plan formulary using the on this site Formulary Browser found at: FormularyBrowser.com or compare how any medication is covered on all Medicare plans in your Service Area using our Drug Finder found at on this site.